Literature DB >> 19499433

Bile acids as possible human carcinogens: new tricks from an old dog.

Vassiliki Costarelli1.   

Abstract

Bile first attracted man's interest long ago. The actual tumour-promoting effects of a bile acid were reported in 1939 for deoxycholic acid. Ever since, much evidence has accumulated that supports an important role for bile acids as cancer promoters in humans through DNA damage and selection for apoptosis-resistant cells, both of which can lead to increased mutation rates. The evidence reviewed here indicates that, in humans, bile acids are likely to be implicated in the aetiology of a number of different important cancers in terms of morbidity and mortality, such as cancer of the colon, oesophagus, stomach, pancreas, gall bladder and cancer of the breast.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19499433     DOI: 10.1080/09637480902970967

Source DB:  PubMed          Journal:  Int J Food Sci Nutr        ISSN: 0963-7486            Impact factor:   3.833


  6 in total

1.  Prediagnostic Plasma Bile Acid Levels and Colon Cancer Risk: A Prospective Study.

Authors:  Tilman Kühn; Magdalena Stepien; Marina López-Nogueroles; Antje Damms-Machado; Disorn Sookthai; Theron Johnson; Marta Roca; Anika Hüsing; Sandra González Maldonado; Amanda J Cross; Neil Murphy; Heinz Freisling; Sabina Rinaldi; Augustin Scalbert; Veronika Fedirko; Gianluca Severi; Marie-Christine Boutron-Ruault; Francesca Romana Mancini; Solomon A Sowah; Heiner Boeing; Paula Jakszyn; Maria J Sánchez; Susana Merino; Sandra Colorado-Yohar; Aurelio Barricarte; Kay Tee Khaw; Julie A Schmidt; Aurora Perez-Cornago; Antonia Trichopoulou; Anna Karakatsani; Paschalis Thriskos; Domenico Palli; Claudia Agnoli; Rosario Tumino; Carlotta Sacerdote; Salvatore Panico; Bas Bueno-de-Mesquita; Carla H van Gils; Alicia K Heath; Marc J Gunter; Elio Riboli; Agustín Lahoz; Mazda Jenab; Rudolf Kaaks
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

2.  An investigation of cross-sectional associations of a priori-selected dietary components with circulating bile acids.

Authors:  Doratha A Byrd; Rashmi Sinha; Stephanie J Weinstein; Demetrius Albanes; Neal D Freedman; Joshua Sampson; Erikka Loftfield
Journal:  Am J Clin Nutr       Date:  2021-11-08       Impact factor: 8.472

3.  Functional metabolome profiling may improve individual outcomes in colorectal cancer management implementing concepts of predictive, preventive, and personalized medical approach.

Authors:  Yu Yuan; Chenxin Yang; Yingzhi Wang; Mingming Sun; Chenghao Bi; Sitong Sun; Guijiang Sun; Jingpeng Hao; Lingling Li; Changliang Shan; Shuai Zhang; Yubo Li
Journal:  EPMA J       Date:  2022-01-27       Impact factor: 6.543

4.  Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer.

Authors:  Guangguo Tan; Haibo Wang; Jianlin Yuan; Weijun Qin; Xin Dong; Hong Wu; Ping Meng
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

5.  Comparison of the composition of bile acids in bile of patients with adenocarcinoma of the pancreas and benign disease.

Authors:  David O Rees; Peter J Crick; Gareth J Jenkins; Yuqin Wang; William J Griffiths; Tim H Brown; Bilal Al-Sarireh
Journal:  J Steroid Biochem Mol Biol       Date:  2017-10-12       Impact factor: 4.292

6.  A high bile acid environment promotes apoptosis and inhibits migration in pancreatic cancer.

Authors:  Shaopu Zhu; Kang Yang; Shiyi Yang; Li Zhang; Maoming Xiong; Jiawei Zhang; Bo Chen
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.